Latest Commercialization News

Lycopodium has secured a A$93 million EPCM contract to expand Artemis Gold’s Blackwater Mine in Canada, boosting the mine’s throughput capacity to one of the largest in the country.

Austral Resources has locked in $15 million from QIC’s Queensland Critical Minerals Fund to advance expansion planning at its Rocklands copper processing facility, aiming to boost capacity beyond 3Mtpa and extend operational life through 2034 and beyond.

Omega Oil & Gas is drilling ahead at the Canyon-3 appraisal well in Queensland’s Taroom Trough, targeting extensive Permian reservoirs that could define a significant new oil and gas province.

Philips has officially declared compatibility for Imricor’s interventional MR devices with its magnetic resonance systems, enabling commercial clinical use and collaboration at a leading cardiology congress.

AVITA Medical posted robust Q2 2026 results with 18% revenue growth, driven by RECELL and supported by Cohealyx and PermeaDerm, and now expects to reach cash flow breakeven by year-end.

James Hardie Industries posted a 64% jump in Q1 FY27 net sales to $1.475 billion, powered by the AZEK acquisition and solid organic growth. The company exceeded EBITDA guidance and raised its full-year outlook, targeting robust sales and cash flow growth amid cautious housing market assumptions.

ReNerve has secured marketing approval for its NervAlign® Nerve Cuff in the Philippines, tapping into a major Southeast Asian market with significant nerve injury demand.

Clarity Pharmaceuticals has presented compelling clinical evidence that its investigational 64Cu-SAR-bisPSMA diagnostic and 67Cu-SAR-bisPSMA therapeutic candidates outperform current standards in prostate cancer care, positioning the company for regulatory and commercial milestones.

EV Resources has secured its first binding five-year ore supply agreement with Chinantla, underpinning its Proof-of-Concept antimony processing campaign at Tecomatlán and advancing its regional hub strategy.

The Calmer Co. has secured a long-term supply agreement for premium noble kava from Papua New Guinea and Vanuatu, underpinning its manufacturing growth and diversified Pacific sourcing network.

Flynn Gold has inked a non-binding Ore Purchase Agreement with Kaiser Reef's Henty Gold Mine, opening a potential low-capital route to production for its Golden Ridge project in Tasmania.

Argent BioPharma's licensing partner Splash Beverage Group has launched the US veterinary development program for CannEpil®, targeting companion-animal oncology and chronic pain. Led by industry veteran Dr Hunter Land, the initiative follows a defined FDA regulatory pathway and could broaden CannEpil®’s commercial footprint beyond human neurology.